A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma

摘要

Background: New emergence of immunotherapy has significantly improved clinical outcome of melanoma patients with advanced and metastatic diseases. We aimed to develop a gene signature based on the expression of PD-1/PD-L1 signaling pathway genes to predict prognosis and immunotherapy response in melanoma patients.